Trial NCT04600895
Publication PRESECO - Golan Y, Clin Infect Dis (2022) (published paper)
Primary outcome on the report: Time to Sustained Clinical Recovery, calculated as the number of days from start of study medication to sustained symptom alleviation, defined by: Oxygen saturation ≥94% at rest, and Oral temperature <38.0°C, and all COVID-19-associated symptoms reaching a score of mild or none for 4 consecutive days.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.